MS Relapses āBelong to the Pastā: Ofatumumab Safety Good Presented ByProf. Stephen L. Hauser , University of California, San Francisco (UCSF), USA TrialASCLEPIOS, ALITHIOS 13 April, 2021 17:28
No new safety signals in ofatumumab open-label data TrialALITHIOS, ASCLEPIOS I, ASCLEPIOS II, APLIOS ConferenceMS Virtual 2020 25 November, 2020 16:57